- Platform Technologies
Professor Leann Tilley and Stanley Cheng Xie from the Bio21 Institute are joining with Takeda Pharmaceuticals in the fight against malarial drug resistance.
NHMRC Project and Fellowship grants received by Bio21 researchers will ensure that important research into neurodegenerative diseases, radiopharmaceuticals, periodontitis, and the tropical diseases leishmaniasis and malaria will continue.
Bio21 research groups' ARC Discovery and LIEF grant success
Hope for the future: biodiversity symposium tackles climate change
Managing Victoria’s Biodiversity under Climate Change: 8-9 October, 2015 @ Bio21
New research from Professor Michael Parker on potential vaccines for S.pneumoniae
Professor Karen Day, distinguished malaria researcher and Dean of Science at the University of Melbourne, has won the 2015 Advance Global Australian Award in recognition of her international leadership in life sciences research and education.
Dr Laura Vella was awarded the 2015 Bio21 Institute Wettenhall Establishment Award to establish her research into the roles vesicles play in neurodegenerative diseases.
Anita Pax is doing a PhD in Mozzarella; its properties and how this is reflected in its molecular structure as part of the ARC’s Dairy Innovation Hub at the Bio21 Institute.
New research conducted by scientists at the Universities of Melbourne and Wollongong and QUT has provided a first glimpse at how free radical damage might be initiated in the human lung upon exposure to the urban air pollutant ozone.
Image for September: Residents of a community in the Upper East Region Ghana